The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Subscribe To Our Newsletter & Stay Updated
